Delta Asset Management LLC Oncternal Therapeutics, Inc. Transaction History

Delta Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.86 - $22.2 $6 - $155	7 New	7 $0
Q1 2022 May 12, 2022	SELL	$1.37 - $2.43 $9 - $17	-7 Closed	0 $0
Q3 2019 Oct 31, 2019	SELL	$3.87 - $6.13 $650 - $1,029	-168 Reduced 96.0%	7 $0
Q2 2019 Jul 26, 2019	BUY	$4.86 - $9.24 $850 - $1,617	175 New	175 $1,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Asset Management LLC with notifications on news.